How the US Food and Drug Administration defines and detects adverse drug events
- 1 September 2001
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 62 (9) , 641-649
- https://doi.org/10.1016/s0011-393x(01)80070-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Epidemiologists and adverse event data—a challenge to the fieldPharmacoepidemiology and Drug Safety, 1999
- Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting SystemThe American Statistician, 1999
- [Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System]: DiscussionThe American Statistician, 1999
- Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational studyBMJ, 1998
- The Incidence of Primary Angle-Closure Glaucoma in Olmsted County, MinnesotaArchives of Ophthalmology (1950), 1997
- Occupation, Employment Status and Chronic Inflammatory Bowel Disease in DenmarkInternational Journal of Epidemiology, 1996